Dilated Cardiomyopathy (DCM) is a critical cardiovascular condition marked by the enlargement of the heart's chambers, particularly the left ventricle. This pathology results in the weakening of the heart muscle, compromising its ability to pump blood effectively. The dilation and diminished pumping function characterize the heart's struggle in maintaining its normal operation. Various factors contribute to the development of DCM, such as genetic predisposition, viral infections, certain medications, and exposure to toxins. Recognizable symptoms often encompass fatigue, shortness of breath, leg swelling, and irregular heartbeat. Identification of DCM in its early stages is crucial for effectively managing the condition and preventing potential complications. Diagnostic measures typically involve a combination of medical history assessments, physical examinations, and advanced cardiac imaging techniques. Treatment strategies for DCM are multifaceted and may involve medications to enhance heart function, mitigate symptoms, and manage underlying causes.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt